Early Access Program With Inolimomab in Steroid-refractory Acute Graft Versus Host Disease
Clinical trial NCT05047328 · AVAILABLE
Trial details
- NCT number
- NCT05047328
- Sponsor
- ElsaLys Biotech
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.